Pacific Biosciences of California

Yahoo Finance • 4 days ago

Jim Gibson to join PacBio as Chief Financial Officer

MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the company’s new Chief Fin... Full story

Yahoo Finance • 14 days ago

Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

MENLO PARK, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful... Full story

Yahoo Finance • last month

PacBio to Participate in TD Cowen's 45th Annual Health Care Conference

MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at TD Cowen's 45th Annual Health C... Full story

Yahoo Finance • last month

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors gr... Full story

Yahoo Finance • 2 months ago

PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results

MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth quarter results Revenue of $39.2 million, a 33% decrease comp... Full story

Yahoo Finance • 2 months ago

PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service

MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company’s new Global Head of... Full story

Yahoo Finance • 2 months ago

PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

PacBio MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2024 financial results on Thursday, February 13, 2025, at 4:3... Full story

Yahoo Finance • 2 months ago

PacBio Announces Appointment of Chris Smith to Board of Directors

MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Chris Smith to its Board of Directors, effective t... Full story

Yahoo Finance • 2 months ago

PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics

MENLO PARK, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leader in high-quality, long-read sequencing, is proud to announce its critical role in a study to be published in Nature Genetics. The study, titled Synchron... Full story

Yahoo Finance • 2 months ago

PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider

MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food Security (GIFS) at the University of Sa... Full story

Yahoo Finance • 7 months ago

Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital

PacBio Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male Infertility Consortium MENLO PARK, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- PacBio... Full story

Yahoo Finance • last year

11 Oversold NASDAQ Stocks To Buy Right Now

In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now. To skip our detailed analysis of current stock market news, you can go directly to see the 5 Oversold NASDAQ Stocks To Buy Right Now. NASDAQ Leads Th... Full story

Yahoo Finance • last year

14 Best Beaten Down Stocks To Buy Right Now

In this piece, we will take a look at the 14 best beaten down stocks to buy right now. If you want to skip our coverage of the latest events in the stock market, then you can take a look at the 5 Best Beaten Down Stocks To Buy Right Now.... Full story

Yahoo Finance • last year

Top 11 CRISPR Stocks To Invest In

In this article, we discuss the top 11 CRISPR stocks to invest in. If you want to skip our discussion of the gene editing industry, head directly to Top 5 CRISPR Stocks To Invest In. Genome editing refers to a set of technologies enabling... Full story

Yahoo Finance • last year

PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale

New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio™ Sequencing System MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing s... Full story

Yahoo Finance • last year

12 Most Promising Gene Editing Stocks According to Hedge Funds

In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can... Full story

Yahoo Finance • last year

12 Best Genomics Stocks To Buy Now

In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there's one t... Full story

Yahoo Finance • 2 years ago

Pacific Biosciences of California Stock Clears Key Benchmark, Hitting 80-Plus RS Rating

Is Pacific Biosciences of California Stock A Buy? Pacific Biosciences of California stock is not currently near a potential buy zone. Pacific Biosciences of California stock earns the No. 19 rank among its peers in the Medical-Systems/Equi... Full story

Yahoo Finance • 2 years ago

PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030

MENLO PARK, Calif., June 26, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. ("PacBio") (NASDAQ: PACB) today announced that it has entered into a privately negotiated exchange agreement with a holder of PacBio's outstanding 1.... Full story

Yahoo Finance • 2 years ago

10 DNA Stocks Billionaires Are Loading Up On

In this article, we discuss 10 DNA stocks that billionaires love. If you want to skip our detailed analysis of the DNA market, head over to 5 DNA Stocks Billionaires Are Loading Up On. Genomics is the study of a complete set of DNA within... Full story